Global Colorectal Cancer Diagnosis and Therapeutics Market Research and Forecast 2018-2023

  • ID: 4471510
  • Report
  • Region: Global
  • Orion Market Research Private Limited
1 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter .
  • Clinical Genomics
  • Epigenomics
  • Genomictree
  • Metabiomics
  • MORE
Colorectal cancer Therapeutics Market is a malignancy that begins in the colon or the rectum. These cancers can likewise be named, colon tumor or rectal cancer depending upon where they begin. There are several factors that are driving the colorectal cancer diagnosis and therapeutics market such as rising number of colorectal cancer, change in the life style of people such as consumption of alcohol, lack of physical activity, inadequate diet, and rising geriatric population. The factors that restrain the market are considered include high cost of screening test, lack of awareness in underdeveloped countries, patent expiry of the drugs and others.

The colorectal cancer diagnosis and therapeutics market has been segmented on the basis of type, treatment, stages, diagnosis and end users. On the basis of type, the market is segmented into adenocarcinomas, carcinoid tumors, lymphomas, sarcomas, and gastrointestinal stromal tumors (GISTs). On the basis of treatment, the market is bifurcated into surgery, radiation therapies, chemotherapy, targeted therapy, and immunotherapy. The market segmentation according to stages is bifurcated into Stage 0, Stage I, Stage II, Stage III, and Stage IV. According to the end users, the market is segmented into multispecialty hospitals and cancer research centers.

Geographically, the global colorectal cancer diagnosis and therapeutics market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. Asia Pacific market is considered to be the fastest growing market globally. The rise in the number of cancer patients in the APAC region is considered to rise eventually enabling the colorectal cancer diagnosis and therapeutics market to grow. North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from government, rise in the key players and various other factors.

The key players in the colorectal cancer diagnosis and therapeutics market include Abbott Diagnostics, Alere, Bayer HealthCare Pharmaceuticals, Boehringer Ingelheim, Beckman Coulter, and others. There are were several points were taken in count such as the number of cases of colorectal cancer, the annual report of the players were studies, driving factors were taken in count and so on.

Market Segmentation:

Global colorectal cancer diagnosis and treatment market is segmented on the basis of, type, by therapies, by diagnosis, by end user, and by regional outlook.
  • Global Colorectal cancer diagnosis and therapeutics Market Research and Analysis, By Treatment
  • Global Colorectal cancer diagnosis and therapeutics Market Research and Analysis, By Diagnosis
  • Global Colorectal cancer diagnosis and therapeutics Market Research and Analysis, By End User
  • Global Colorectal cancer diagnosis and therapeutics Market Research and Analysis, By Region
Report Covers:
  • Comprehensive research methodology of Global Colorectal cancer diagnosis and therapeutics market.
  • This report also includes detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Colorectal cancer diagnosis and therapeutics market.
  • Insights about market determinants which are stimulating the Global Colorectal cancer diagnosis and therapeutics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Diagnostics
  • Beckman Coulter .
  • Clinical Genomics
  • Epigenomics
  • Genomictree
  • Metabiomics
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. by Segments
1.2.2. by Geography
1.2.3. by Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World
2.4. Patent Analysis

3. Market Determinant
3.1. Motivators
3.1.1. Changing Lifestyle Such as Lack of Physical Inactivity, Obesity Increases the Chances of Colorectral Cancer
3.1.2. Development of Advance Therapies Such as Targeted Therapy
3.1.3. Increased Investment From Governmnet and Private Bodies
3.1.4. Increasing Awareness Among the Individual in Developed Nation
3.2. Restraints
3.2.1. High Cost of Screening Test
3.2.2. Patent Expiry of Existing Drug
3.3. Opportunities
3.3.1. R&D and Technological Advancement
3.3.2. Emerging Market Such as APAC Region

4. Market Segmentation
4.1. Global Colorectal Cancer Diagnosis and Therapeutics Market, by Type
4.1.1. Adenocarcinomas
4.1.2. Carcinoid Tumors
4.1.3. Lymphomas
4.1.4. Sarcomas
4.1.5. Gastrointestinal Stromal Tumors (Gists)
4.2. Global Colorectal Cancer Diagnosis and Therapeutics Market, by Treatment
4.2.1. Surgery
4.2.2. Radiation Therapy
4.2.3. Chemotherapy
4.2.4. Targeted Therapy
4.2.5. Immunotheraphy
4.3. Global Colorectal Cancer Diagnosis and Therapeutics Market, by Diagnosis
4.3.1. Digital Rectal Examination
4.3.2. Fecal Occult Blood Test
4.3.3. Flexible Sigmoidoscopy
4.3.4. Colonoscopy
4.3.5. Others
4.4. Global Colorectal Cancer Diagnosis and Therapeutics Market, by End User
4.4.1. Multispeciality Hospitals
4.4.2. Cancer Research Centers

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Diagnostics
7.2. Alere
7.3. Bayer Healthcare Pharmaceuticals
7.4. Boehringer Ingelheim
7.5. Beckman Coulter .
7.6. Clinical Genomics
7.7. EDP Biotech
7.8. Epigenomics
7.9. Exact Sciences
7.10. Genomictree
7.11. Merck Kgaa
7.12. Metabiomics
7.13. Quest Diagnostics
7.14. Randox Laboratories
7.15. Roche Ltd.
7.16. Siemens Healthcare
7.17. Taiho Pharmaceutical
7.18. Volition Rx.

List of Tables:
Table 1 Global Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Geography, 2017-2023,
Table 2 Global Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($ Million)
Table 3 Global Adenocarcinomas Market Research and Analysis, 2017-2023, ($ Million)
Table 4 Global Carcinoid Tumors Market Research and Analysis, 2017-2023, ($ Million)
Table 5 Global Lymphomas Market Research and Analysis, 2017-2023, ($ Million)
Table 6 Global Sarcomas Market Research and Analysis, 2017-2023, ($ Million)
Table 7 Global Gastrointestinal Stromal Tumors (Gists) Market Research and Analysis, 2017-2023, ($ Million)
Table 8 Global Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Treatment 2017-2023($ Million)
Table 9 Global Surgery Market Research and Analysis, 2017-2023, ($ Million)
Table 10 Global Radiation Therapy Market Research and Analysis, 2017-2023, ($ Million)
Table 11 Global Chemotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 12 Global Targeted Therapy Market Research and Analysis, 2017-2023, ($ Million)
Table 13 Global Immunotherapy Market Research and Analysis, 2017-2023, ($ Million)
Table 14 Global Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis, 2017-2023, ($ Million)
Table 15 Global Digital Rectal Examination Market Research and Analysis, 2017-2023, ($ Million)
Table 16 Global Fecal Occult Blood Test Market Research and Analysis, 2017-2023, ($ Million)
Table 17 Global Flexible Sigmoidoscopy Market Research and Analysis, 2017-2023, ($ Million)
Table 18 Global Colonoscopy Market Research and Analysis, 2017-2023, ($ Million)
Table 19 Global Others Market Research and Analysis, 2017-2023, ($ Million)
Table 20 Global Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023, ($ Million)
Table 21 Global Multispecialty Hospitals Market Research and Analysis, 2017-2023, ($ Million)
Table 22 Global Cancer Research Institute Market Research and Analysis, 2017-2023, ($ Million)
Table 23 Merger and Acquisition
Table 24 Global Colorectal Cancer Diagnosis and Therapeutics Market, by Geography 2016-20122($ Million)
Table 25 North America Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 26 North America Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Treatment 2017-2023($Million)
Table 27 North America Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 28 North America Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 29 North America Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 30 Europe Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 31 Europe Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Treatment 2017-2023($Million)
Table 32 Europe Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 33 Europe Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 34 Europe Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 35 Asia Pacific Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 36 Asia Pacific Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Treatment 2017-2023($Million)
Table 37 Asia Pacific Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 38 Asia Pacific Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)
Table 39 Asia Pacific Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Countries 2017-2023($Million)
Table 40 Rest of the World Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Type 2017-2023($Million)
Table 41 Rest of the Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Treatment 2017-2023($Million)
Table 42 Rest of the World Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by Diagnosis 2017-2023($Million)
Table 43 Rest of the World Colorectal Cancer Diagnosis and Therapeutics Market Research and Analysis, by End User 2017-2023($Million)Figure 1 Global Colorectal Cancer Diagnosis and Therapeutics Market Share, by Type 2017 and 2023, (In %)
Figure 2 Global Colorectal Cancer Diagnosis and Therapeutics Market Share, by Treatment 2017 and 2023, (In %)
Figure 3 Global Colorectal Cancer Diagnosis and Therapeutics Market Share, by Diagnosis 2017 and 2023, (In %)
Figure 4 Global Colorectal Cancer Diagnosis and Therapeutics Market Share, by End User 2017 and 2023, (In %)
Figure 5 Global Colorectal Cancer Diagnosis and Therapeutics Market Share, by Geography 2017 and 2023, (In %)
Figure 6 North America Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 7 US Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 8 Canada Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 9 European Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 10 UK Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 11 France Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 12 Germany Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 13 Italy Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 14 Spain Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 15 ROE Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 16 Asia Pacific Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 17 India Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 18 China Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 19 Japan Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 20 RoAPAC Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Figure 21 Rest of the World Colorectal Cancer Diagnosis and Therapeutics Market Size, 2017-2023 ($Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Diagnostics
  • Alere
  • Bayer Healthcare Pharmaceuticals
  • Boehringer Ingelheim
  • Beckman Coulter .
  • Clinical Genomics
  • Edp Biotech
  • Epigenomics
  • Exact Sciences
  • Genomictree
  • Merck Kgaa
  • Metabiomics
  • Quest Diagnostics
  • Randox Laboratories
  • Roche Ltd.
  • Siemens Healthcare
  • Taiho Pharmaceutical
  • Volition Rx.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll